Trials / Completed
CompletedNCT00140959
Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)
Antihypertensive Effects of a Fixed-dose Combination of Losartan and Hydrochlorothiazide Plus Amlodipine Versus a Hydrochlorothiazide and Atenolol Combination Plus Amlodipine in Subjects With Ambulatory Systolic Hypertension.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954, losartan potassium/Duration of Treatment: 18 weeks | |
| DRUG | Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks |
Timeline
- Start date
- 2003-02-01
- Primary completion
- 2004-06-30
- Completion
- 2004-06-30
- First posted
- 2005-09-01
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00140959. Inclusion in this directory is not an endorsement.